23 August 2019 - Genmab A/S (CPH: GMAB), a biotechnology company specialising in the creation and development of differentiated antibody therapeutics for the treatment of cancer, announced on Thursday the approval by the Ministry of Health, Labour an...
23 August 2019 - Science-led biopharmaceutical company AstraZeneca Plc (LON:AZN) announced on Thursday that it has agreed to buy a US Food and Drug Administration (FDA) Priority Review Voucher (PRV) for a total cash consideration of USD95m from a sub...
23 August 2019 - Science-led biopharmaceutical company AstraZeneca Plc (LON:AZN) announced on Thursday the receipt by its partner FibroGen (China) Medical Technology Development Co Ltd (FibroGen China) of marketing authorisation for roxadustat in Chi...
23 August 2019 - Healthcare company CrossBay Medical Inc reported on Thursday the receipt of marketing clearance to commercialise its Endometrial Tissue Sampler (ETS) using CrossGlide technology for use in endometrial biopsy procedures in Europe.Cros...
23 August 2019 - Biopharmaceutical company Satsuma Pharmaceuticals Inc reported on Thursday the dosing of the first patient under its Phase 3 EMERGE efficacy trial of STS101 (dihydroergotamine (DHE) nasal powder) for the acute treatment of migraine.T...